Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00597441 · ClinicalTrials.gov registry record · Phase 1

Phase I Study of Umbilical Cord Blood Transplantation Followed by Third Party Thymus Transplantation

A Phase 1 study, sponsored by Sumitomo Pharma Switzerland.

Terminated
Registry status
Phase 1
Development phase
6
Enrollment target

NCT00597441: Clinical Trial Phase 1 study, sponsored by Sumitomo Pharma Switzerland.

NCT00597441 is a Phase 1 study that was terminated before completion, run by Sumitomo Pharma Switzerland. The registered enrollment target is 6 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00597441, a Phase 1 study, was terminated before completion, sponsored by Sumitomo Pharma Switzerland.

TERMINATED
Registry status
Phase 1
Development phase
6 participants
Enrollment target

Study Summary

The objective of this trial is to assess the toxicity of thymus transplantation following unrelated umbilical cord blood transplantation. Emphasis will be placed on adverse events that are not typically associated with umbilical cord blood transplantation. Also, to determine whether engraftment of a third party thymus allograft is feasible in patients who have undergone unrelated umbilical cord blood transplantation.

Interventions

  • BIOLOGICAL Thymic Transplantation for Recipients of UCB transplant

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2005-11
Est. Completion 2010-05
Phase Phase 1
Sumitomo Pharma Switzerland

13 total trials

Why NCT00597441 stopped before completion

NCT00597441 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 1 intervention - of which Thymic Transplantation for Recipients of UCB transplant is the first listed.

NCT00597441 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00597441 about?

NCT00597441 is a clinical study titled "Phase I Study of Umbilical Cord Blood Transplantation Followed by Third Party Thymus Transplantation". The objective of this trial is to assess the toxicity of thymus transplantation following unrelated umbilical cord blood transplantation. Emphasis will be placed on adverse events that are not typically associated with umbilical cord blood transplantation. Also, to determine whether engraftment of a...

What is the current status of trial NCT00597441?

This trial is currently terminated. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2005-11. Estimated completion is 2010-05.

What interventions are being tested in trial NCT00597441?

The interventions under investigation include: Thymic Transplantation for Recipients of UCB transplant (BIOLOGICAL).

Who is sponsoring clinical trial NCT00597441?

This trial is sponsored by Sumitomo Pharma Switzerland, which has 13 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00597441's enrollment target sits among peer trials

6 1974th of 2000 higher than 12 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-07-11

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT00573027 · started 2005-11 · NA

    Heart Disease of the Small Arteries in Women and Men

  • NCT01803451 · started 2005-11 · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT00493688 · started 2005-10-30

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

  • NCT03160274 · started 2005-10-19

    Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions

Source: ClinicalTrials.gov NCT00597441, the US trial registry maintained by the National Library of Medicine. NCT00597441 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.